Yamada Y, Matsuhashi N, Fujii H, Makiyama A, et al. Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept. Anticancer Res 2021;41:533-541.
PMID: 33419853